These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3106799)

  • 21. Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53.
    Greenwood SK; Armstrong MJ; Hill RB; Bradt CI; Johnson TE; Hilliard CA; Galloway SM
    Mutat Res; 1998 Jun; 401(1-2):39-53. PubMed ID: 9639670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology of cell killing by 1-beta-D-arabinofuranosylcytosine and its relevance to molecular mechanisms of cytotoxicity.
    Crowther PJ; Cooper IA; Woodcock DM
    Cancer Res; 1985 Sep; 45(9):4291-300. PubMed ID: 4028015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Aminobenzamide is lethal to MMS-damaged human fibroblasts primarily during S phase.
    Boorstein RJ; Pardee AB
    J Cell Physiol; 1984 Sep; 120(3):345-53. PubMed ID: 6430922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
    Gledhill RM; Edwards AJ; Norman MR
    Br J Cancer; 1983 May; 47(5):649-57. PubMed ID: 6573907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of the development of accelerated cell-cycle transit resulting from inhibition of DNA replication in the previous cycle.
    Tolmach LJ; Labanowska J
    Cell Tissue Kinet; 1990 Mar; 23(2):125-35. PubMed ID: 2107975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for double replication of chromosomal DNA segments as a general consequence of DNA replication inhibition.
    Woodcock DM; Cooper IA
    Cancer Res; 1981 Jun; 41(6):2483-90. PubMed ID: 7237443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Boise L; Westin E; Howe C; Pettit GR; Turner A; McCrady C
    Biochem Pharmacol; 1991 Jul; 42(4):853-67. PubMed ID: 1867641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on the generation of DNA strand breaks in a human promyelocytic leukemia cell line.
    Tanizawa A; Kubota M; Takimoto T; Kito T; Akiyama Y; Kiriyama Y; Mikawa H
    Leuk Res; 1989; 13(2):151-6. PubMed ID: 2494390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells.
    Fram RJ; Robichaud N; Bishov SD; Wilson JM
    Cancer Res; 1987 Jul; 47(13):3360-5. PubMed ID: 3107809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
    Fietkau R; Friede H; Maurer-Schultze B
    Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.
    Fingert HJ; Chang JD; Pardee AB
    Cancer Res; 1986 May; 46(5):2463-7. PubMed ID: 3084068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependent changes in H1 content, H1 turnover, DNA elongation, and the survival of cells blocked in early S phase by hydroxyurea, aphidicolin, or 5-fluorodeoxyuridine.
    D'Anna JA; Crissman HA; Jackson PJ; Tobey R
    Biochemistry; 1985 Sep; 24(19):5020-6. PubMed ID: 2934087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of novobiocin on the frequency of chromosome-type aberrations induced by ara C in the G1 phase of human lymphocytes.
    Kishi K
    Mutat Res; 1988 Jun; 208(2):109-13. PubMed ID: 3132613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA repair and chromosome aberrations: the effect of cytosine arabinoside on the frequency of chromosome aberrations induced by radiation and chemicals.
    Preston RJ
    Teratog Carcinog Mutagen; 1980; 1(2):147-59. PubMed ID: 6119807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens.
    Galloway SM; Miller JE; Armstrong MJ; Bean CL; Skopek TR; Nichols WW
    Mutat Res; 1998 May; 400(1-2):169-86. PubMed ID: 9685628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cytosine arabinoside and daunorubicin on survival and cell cycle progression of Chinese hamster ovary cells.
    Fried J; Perez AG; Doblin J; Clarkson BD
    Cell Tissue Kinet; 1982 Jan; 15(1):11-23. PubMed ID: 7199386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells.
    Sun D; Urrabaz R; Buzello C; Nguyen M
    Exp Cell Res; 2002 Oct; 280(1):90-6. PubMed ID: 12372342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repair-induced DNA double strand breaks after ultraviolet-light and either aphidocolin or 1-beta-D-arabinofuranosylcytosine/hydroxyurea.
    Bradley MO; Taylor VI
    Carcinogenesis; 1983 Dec; 4(12):1513-7. PubMed ID: 6418402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular aspects of the action of cytosine arabinoside.
    Valeriote F
    Med Pediatr Oncol; 1982; 10 Suppl 1():5-26. PubMed ID: 7162467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aphidicolin inhibits cell growth by accumulation of G2 cells.
    Fukuda M; Ohashi M
    Cell Biol Int Rep; 1983 Aug; 7(8):579-85. PubMed ID: 6413078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.